We have prepared self-assembled polymeric drug carriers containing fluorophore and loaded drugs for theragnostic imaging of tumors. This new type of polymeric drug carriers visualizes the accumulation of carriers at tumor sites, and evaluates therapeutic efficacies, and thereby providing an exciting new tool for monitering tumor diagnosis and therapy.
Ick Chan Kwon is currently Head of Biomedical Research Center at Korea Institute of Science and Technology (KIST). He received his B.S. and M.S. degrees from the College of Engineering at Seoul National University in 1982 and 1984 and his Ph. D. in pharmaceutics and pharmaceutical chemistry from University of Utah in 1993. After a post-doctoral training in Center for Controlled Chemical Delivery at University of Utah, he joined KIST in 1994.
He is currently a vice president of the Korean Society of Molecular Imaging (2005-2006, 2007-2008). He also serves as an Associate Editor of the Journal of Controlled Release,
Asian Editor of the Journal of Biomedical Nanotechnology
and a member of editorial boards of Journal of Biomedical Engineering Research, Macromolecular Research,
and J. Biomaterials Science, Polymer Edition.
His main research interest is targeted drug delivery with polymeric nanoparticles and is now expanding to the development of smart nano-probes for theragnostic imaging. He is a project leader of “Real-time molecular imaging” supported from the Ministry of Science and Technology of Korea. He has published over 100 peer-reviewed papers, 11 book chapters, and 6 review articles. He also made over 60 national as well as international invited lectures.
In conjunction with:
Kwangmeyung Kim1,2, Kyeongsoon Park1,2, Seulki Lee1,2, Kuiwon Choi1, In-San Kim2 (Korea Institute of Science and Technology, Seoul, Korea) and (Kyungpook National University, Korea).
Researchers should cite this work as follows:
Ick Chan Kwon (2007), "KIST/PU Tumor-Homing Chitosan-Based Nanoparticles for Cancer Theragnosis; Imaging, Drug Delivery and Therapy," http://nanohub.org/resources/3401.